Completed PHASE3 INTERVENTIONAL 1-arm NCT00000167

Complications of Age-Related Macular Degeneration Prevention Trial (CAPT)

Sponsor: National Eye Institute (NEI)

Interventions Low-Intensity Laser Treatment

Updated 6 times since 2017 Last updated: Mar 23, 2010 Started: May 31, 1999 Completion: Jun 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00000167, this PHASE3 trial focuses on Macular Degeneration and remains completed. Sponsored by National Eye Institute (NEI), it has been updated 6 times since 1999, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

6 versions recorded

Sep 2025 — Present [monthly]

Completed PHASE3
Sep 2024 — Sep 2025 [monthly]

Completed PHASE3
Jul 2024 — Sep 2024 [monthly]

Completed PHASE3
Jan 2021 — Jul 2024 [monthly]

Completed PHASE3
Jun 2018 — Jan 2021 [monthly]

Completed PHASE3

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Completed PHASE3

First recorded

May 1999

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Eye Institute (NEI)

Data source: National Eye Institute (NEI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Atlanta, United States , Baltimore, United States , Boston, United States , Charlotte, United States , Chicago, United States , Cleveland, United States , Columbus, United States , Dallas, United States , Edison, United States , Harvey, United States and 13 more locations